1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of autologous hematopoietic cell transplantation in diffuse large B cell lymphoma refractory to firstline chemoimmunotherapy
    Journal Article

    Bal, S.; Costa, L. J.; Sauter, C.; Litovich, C.; Hamadani, M.
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in human immunodeficiency virus-associated, B-cell non-Hodgkin lymphoma
    Journal Article

    Sparano, J. A.; Lee, J. Y.; Kaplan, L. D.; Ramos, J. C.; Ambinder, R. F.; Wachsman, W.; Aboulafia, D.; Noy, A.; Henry, D. H.; Ratner, L.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies
    Journal Article

    Armand, P.; Lesokhin, A.; Borrello, I.; Timmerman, J.; Gutierrez, M.; Zhu, L.; McKiver, M. P.; Ansell, S. M.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin
    Journal Article

    Politikos, I.; Devlin, S. M.; Arcila, M. E.; Barone, J. C.; Maloy, M. A.; Naputo, K. A.; Ruiz, J. D.; Mazis, C. M.; Scaradavou, A.; Avecilla, S. T.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • The experience of financial toxicity among advanced melanoma patients treated with immunotherapy
    Journal Article

    Thom, B.; Mamoor, M.; Lavery, J. A.; Baxi, S. S.; Khan, N.; Rogak, L. J.; Sidlow, R.; Korenstein, D.
    Journal of Psychosocial Oncology (2021)

    Fulltext@MSK | Save
  • Accelerated and blast phase myeloproliferative neoplasms
    Review

    Jain, T.; Rampal, R. K.
    Hematology/Oncology Clinics of North America (2021)

    Fulltext@MSK | Save
  • The new science and concepts that underlie current and future treatments for myeloproliferative neoplasms
    Editorial

    Hoffman, R.; Levine, R.; Mascarenhas, J.; Rampal, R. K.
    Hematology/Oncology Clinics of North America (2021)

    Fulltext@MSK | Save
  • Epigenetic dysregulation of myeloproliferative neoplasms
    Review

    Dunbar, A.; Park, Y.; Levine, R.
    Hematology/Oncology Clinics of North America (2021)

    Fulltext@MSK | Save
  • Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary study
    Journal Article

    Boerner, T.; Walch, H. S.; Nguyen, B.; Iasonos, A.; Zhou, Q. C.; Schultz, N.; Chui, M. H.; Grisham, R. N.; Tew, W. P.; O'Cearbhaill, R. E.; more...
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Quality of life effect of the anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat in patients with cutaneous T-cell lymphoma
    Journal Article

    Porcu, P.; Hudgens, S.; Horwitz, S.; Quaglino, P.; Cowan, R.; Geskin, L.; Beylot-Barry, M.; Floden, L.; Bagot, M.; Tsianakas, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save